• News
  • SAN DIEGO
  • Health

Sorrento Therapeutics adds Amar Singh as executive VP

Sorrento Therapeutics Inc. (Nasdaq: SRNE) has appointed Amar Singh to be its executive vice president and chief business officer, the late-stage clinical oncology company reported Wednesday.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Sorrento Therapeutics Inc.

Company Website

6042 Cornerstone Ct. West Ste., B
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
SRNE
16.57
  -0.33  
- 1.95%
580,283,000
17.8
3.1

Sorrento Therapeutics Inc. Executive(s):

Henry Ji

  • Chief Executive Officer

Richard Vincent

  • Chief Financial Officer

Similar Companies

NAICS - 541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Subscribe Today!